Massimo Tempestilli
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
Papers in
-
- HIV/AIDS drug development and treatment 16
- COVID-19 Clinical Research Studies 4
- Virology 9
- Poxvirus research and outbreaks 5
- HIV Research and Treatment 4
- Co-authors
- Leopoldo Paolo Pucillo (19 shared papers)Chiara Agrati (13 shared papers)Federico Martini (6 shared papers)Emanuele Nicastri (16 shared papers)Pasquale Narciso (13 shared papers)Stefania Notari (9 shared papers)Cristiana Gioia (3 shared papers)Andrea Antinori (16 shared papers)
In The Last Decade
Massimo Tempestilli
46 papers receiving 837 citations
Peers
Comparison fields: 5 of 77
- Virology 83
- Infectious Diseases 302
- Analytical Chemistry 87
- Immunology 103
- Pharmacology 43
Countries citing papers authored by Massimo Tempestilli
This map shows the geographic impact of Massimo Tempestilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Tempestilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Tempestilli more than expected).
Fields of papers citing papers by Massimo Tempestilli
This network shows the impact of papers produced by Massimo Tempestilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Tempestilli. The network helps show where Massimo Tempestilli may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Tempestilli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 96 | |
| 2 | 2020 | 90 | |
| 3 | 2008 | 84 | |
| 4 | 2015 | 65 | |
| 5 | 2009 | 54 | |
| 6 | 2018 | 48 | |
| 7 | 2017 | 35 | |
| 8 | 2009 | 31 | |
| 9 | 2010 | 28 | |
| 10 | 2023 | 28 | |
| 11 | 2009 | 23 | |
| 12 | 2014 | 21 | |
| 13 | 2005 | 20 | |
| 14 | 2010 | 20 | |
| 15 | 2010 | 16 | |
| 16 | 2012 | 15 | |
| 17 | 2015 | 15 | |
| 18 | 2012 | 14 | |
| 19 | 2011 | 13 | |
| 20 | 2013 | 13 |
About Massimo Tempestilli
Massimo Tempestilli is a scholar working on Infectious Diseases, Virology, Pharmacology, Analytical Chemistry and Hepatology, having authored 50 papers that have together received 865 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Hepatitis C virus research (5 papers), Poxvirus research and outbreaks (5 papers), HIV Research and Treatment (4 papers), COVID-19 Clinical Research Studies (4 papers) and Clinical Laboratory Practices and Quality Control (3 papers). The work is most often cited by research in Virology (83 citations), Infectious Diseases (302 citations), Analytical Chemistry (87 citations), Immunology (103 citations) and Pharmacology (43 citations). Massimo Tempestilli has collaborated with scholars based in Italy, France and Sweden. Frequent co-authors include Leopoldo Paolo Pucillo, Chiara Agrati, Federico Martini, Emanuele Nicastri, Pasquale Narciso, Stefania Notari, Cristiana Gioia, Andrea Antinori, Fabrizio Poccia and Alessandra Sacchi. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, AIDS, Current HIV Research, IUBMB Life and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.